PaxMedica, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Sep-30-21	Jun-30-21	Jun-30-20
	10-Q	10-Q	S-1	10-Q	10-Q	S-1	10-Q	S-1/A
Cash flows from operating activities
Net income (loss)	-3.5	-3.8		0.0	1.9

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation	1.3	2.2		0.1	0.2
Change in fair value of notes
Change in fair value of SAFE
Loss on extinguishment of debt		0.0	0.0
Loss on issuance of debt				0.3
Change in fair value warrant liability				0.0	-2.2
Other expense	0.0	0.1
Deferred revenue	0.5
Changes in assets and liabilities:
Prepaid and other current assets	-0.8	-0.5
Accounts receivable	-0.5
Accounts payable	0.2	0.1		-1.2	1.1
Accounts payable - related party		0.0		0.1	0.1
Accrued expenses	-0.1	-0.8		0.9	0.2
Net cash used in operating activities	-2.8	-3.0	0.0	-1.0	-0.4

Cash flows from financing activities
Proceeds from issuance of convertible promissory notes and warrants		3.2		1.0
Payment of costs in connection with convertible promissory notes and warrants		-0.5
Proceeds from the issuance of common stock in connection with equity purchase agreement	2.0	2.8
Payment of costs in connection with equity purchase agreement	-0.2
Repayment of convertible promissory notes		-0.2
Settlement of shares withheld for payment of employee taxes	0.0
Net cash provided by financing activities	1.9	5.1		1.0
Net increase (decrease) in cash	-0.9	2.1		0.0	-0.4

Non-cash financing activities:
Reclassification of shares settled liability	0.0	0.1
Unpaid deferred offering costs and financing fees		0.0		0.1	0.3